Temat: "Fibroblast Growth Factor-23" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Serum α-Klotho and fibroblast growth factor 23 levels are not associated with non-proliferative diabetic retinopathy in type 1 diabetes mellitus.
Autorzy:: Oner C; Department of Family Medicine, Health Sciences University Kartal Dr Lutfi Kirdar City Hospital, Istanbul, Turkey. .
Dogan B; Department of Family Medicine, Health Sciences University Gulhane Training and Research Hospital, Ankara, Turkey.
Tuzun S; Department of Family Medicine, Health Sciences University Haseki Sultangazi Training and Research Hospital, Istanbul, Turkey.
Ekinci A; Department of Ophtalmology, Health Sciences University Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.
Feyizoglu G; Department of Internal Medicine, Goztepe Prof Dr Suleyman Yalcın City Hospital, Istanbul, Turkey.
Basok BI; Department of Medical Biochemistry, Health Sciences University Tepecik Training and Research Hospital, Izmir, Turkey.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 19; Vol. 14 (1), pp. 4054. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus, Type 1*/complications
Diabetic Retinopathy*/etiology
Fibroblast Growth Factor-23*/blood
Fibroblast Growth Factor-23*/chemistry
Klotho Proteins*/blood
Klotho Proteins*/chemistry
Humans ; Case-Control Studies ; Fibroblast Growth Factors/metabolism ; Glucuronidase

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Fibroblast growth factor 23 regulates hypoxia‑induced osteoblast apoptosis through the autophagy‑signaling pathway.
Autorzy:: Yin Q; Institute of Sports Medicine, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, Shandong 271016, P.R. China.
Yang H; School of Nursing, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, Shandong 271016, P.R. China.
Fang L; Institute of Sports Medicine, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, Shandong 271016, P.R. China.
Wu Q; Department of Rehabilitation and Physiotherapy, Taian Maternal and Child Health Hospital, Taian, Shandong 271000, P.R. China.
Gao S; School of Pharmaceutical Science, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, Shandong 271016, P.R. China.
Wu Y; Institute of Sports Medicine, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, Shandong 271016, P.R. China.
Zhou L; Institute of Sports Medicine, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, Shandong 271016, P.R. China.; Pokaż więcej
Źródło:: Molecular medicine reports [Mol Med Rep] 2023 Nov; Vol. 28 (5). Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:: Journal Article
MeSH Terms:: Fibroblast Growth Factor-23*
MicroRNAs*/genetics
Apoptosis/genetics ; Autophagy/genetics ; Signal Transduction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Research progress of fibroblast growth factor 23 in acute kidney injury.
Autorzy:: Zhang L; Division of Nephrology, Department of Medicine, West China Hospital, Sichuan University, 37 Guoxue Lane, Chengdu, 610041, Sichuan, China.; Division of Nephrology, Henan Key Laboratory for Kidney Disease and Immunology, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Qin W; Division of Nephrology, Department of Medicine, West China Hospital, Sichuan University, 37 Guoxue Lane, Chengdu, 610041, Sichuan, China. .; Pokaż więcej
Źródło:: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2023 Jul; Vol. 38 (7), pp. 2013-2022. Date of Electronic Publication: 2022 Nov 22.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Fibroblast Growth Factor-23*
Acute Kidney Injury*/diagnosis
Humans ; Fibroblast Growth Factors/metabolism ; Biomarkers ; Bone and Bones/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Oncostatin M is a regulator of fibroblast growth factor 23 (FGF23) in UMR106 osteoblast-like cells.
Autorzy:: Münz S; Department of Physiology, University of Hohenheim, Stuttgart, Germany.
Feger M; Department of Physiology, University of Hohenheim, Stuttgart, Germany.
Föller M; Department of Physiology, University of Hohenheim, Stuttgart, Germany. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 May 24; Vol. 13 (1), pp. 8420. Date of Electronic Publication: 2023 May 24.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Fibroblast Growth Factor-23*
Oncostatin M*
Osteoblasts*
Cytokine Receptor gp130 ; Receptors, Oncostatin M ; Animals ; Rats

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia.
Autorzy:: Figurek A; Institute of Anatomy, University of Zurich, 8057 Zurich, Switzerland.
Rroji M; Department of Nephrology, Faculty of Medicine, University of Medicine Tirana, 1001 Tirana, Albania.
Spasovski G; University Clinic for Nephrology, Medical Faculty, University St. Cyril and Methodius, 1000 Skopje, North Macedonia.; Pokaż więcej
Źródło:: Cells [Cells] 2023 Feb 13; Vol. 12 (4). Date of Electronic Publication: 2023 Feb 13.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Anemia*
Renal Insufficiency, Chronic*/metabolism
Fibroblast Growth Factor-23*/metabolism
Humans ; Endothelial Cells/metabolism ; Myocytes, Cardiac/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: FGF23 promotes proliferation, migration and invasion by regulating miR-340-5p in osteosarcoma.
Autorzy:: Fang L; Institute of Sports Medicine, Shandong First Medical University and Shandong Academy Medical Sciences, 619 Changcheng Road, Taian, 271016, Shandong, People's Republic of China.
Li Z; Institute of Sports Medicine, Shandong First Medical University and Shandong Academy Medical Sciences, 619 Changcheng Road, Taian, 271016, Shandong, People's Republic of China.
Yu B; Institute of Sports Medicine, Shandong First Medical University and Shandong Academy Medical Sciences, 619 Changcheng Road, Taian, 271016, Shandong, People's Republic of China.
Zhou L; Institute of Sports Medicine, Shandong First Medical University and Shandong Academy Medical Sciences, 619 Changcheng Road, Taian, 271016, Shandong, People's Republic of China. .; Clinical Center for Sports Medicine and Rehabilitation, The Affiliated Hospital of Shandong First Medical University, 706 Taishan Great Street, Taian, 271000, Shandong, People's Republic of China. .; Pokaż więcej
Źródło:: Journal of orthopaedic surgery and research [J Orthop Surg Res] 2023 Jan 05; Vol. 18 (1), pp. 12. Date of Electronic Publication: 2023 Jan 05.
Typ publikacji:: Journal Article
MeSH Terms:: Bone Neoplasms*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Osteosarcoma*/pathology
Fibroblast Growth Factor-23*/genetics
Fibroblast Growth Factor-23*/metabolism
Humans ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Prediction of Acute Kidney Injury by Fibroblast Growth Factor 23 (FGF-23) in Adult Patients, A Meta-analysis Study.
Autorzy:: Tao W
Guo SW
Fan YJ
Zheng F; Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044, China. .; Pokaż więcej
Źródło:: Iranian journal of kidney diseases [Iran J Kidney Dis] 2023 Jan; Vol. 1 (1), pp. 1-8.
Typ publikacji:: Meta-Analysis; Journal Article; Comment
MeSH Terms:: Acute Kidney Injury*/diagnosis
Fibroblast Growth Factor-23*
Adult ; Humans ; Prospective Studies ; ROC Curve ; Sensitivity and Specificity

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Circulating Fibroblast Growth Factor-23 Levels Can Predict Rapid Kidney Function Decline in a Healthy Population: A Community-Based Study.
Autorzy:: Chen HY; School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Division of Chinese Internal Medicine, Center for Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan.
Fang WC; Department of Family Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan.
Chu SC; Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.
Wang PH; Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.
Lee CC; Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.; College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Community Medicine Research Center, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.
Wu IW; Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.; College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Community Medicine Research Center, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.
Sun CY; Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.; College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Hsu HJ; Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.; College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Community Medicine Research Center, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.
Chen CY; Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.; College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Community Medicine Research Center, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.
Chen YC; College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Division of Nephrology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan 333, Taiwan.
Wu VC; Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei 100, Taiwan.
Pan HC; Division of Nephrology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.; College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Community Medicine Research Center, Keelung Chang Gung Memorial Hospital, Keelung 204, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2022 Dec 24; Vol. 13 (1). Date of Electronic Publication: 2022 Dec 24.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Fibroblast Growth Factor-23*
Renal Insufficiency, Chronic*
Humans ; Kidney Function Tests ; Glomerular Filtration Rate ; Kidney

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Impact of etelcalcetide on fibroblast growth factor-23 and calciprotein particles in patients with secondary hyperparathyroidism undergoing haemodialysis.
Autorzy:: Hashimoto Y; Department of Nephrology, Nagoya University Graduate School of Medicine, Aichi, Japan.
Kato S; Department of Nephrology, Nagoya University Graduate School of Medicine, Aichi, Japan.
Kuro-O M; Division of Anti-Aging Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
Miura Y; Division of Anti-Aging Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
Itano Y; Department of Nephrology, Nagoya University Graduate School of Medicine, Aichi, Japan.
Ando M; Department of Advanced Medicine, Nagoya University Hospital, Aichi, Japan.
Kuwatsuka Y; Department of Advanced Medicine, Nagoya University Hospital, Aichi, Japan.
Maruyama S; Department of Nephrology, Nagoya University Graduate School of Medicine, Aichi, Japan.; Pokaż więcej
Źródło:: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2022 Sep; Vol. 27 (9), pp. 763-770. Date of Electronic Publication: 2022 Jul 05.
Typ publikacji:: Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:: Fibroblast Growth Factor-23*
Hyperparathyroidism, Secondary*/diagnosis
Hyperparathyroidism, Secondary*/drug therapy
Hyperparathyroidism, Secondary*/etiology
Calcium ; Fibroblast Growth Factors ; Humans ; Parathyroid Hormone ; Peptides ; Renal Dialysis/adverse effects ; Vitamin D

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Association of serum 25-hydroxyvitamin D3, fibroblast growth factor-23, and C1q/tumor necrosis factor-related protein-3 with coronary artery calcification in nondialysis chronic kidney disease patients.
Autorzy:: Zhu Y; Graduate School, North China University of Science, Tangshan, China.; Department of Nephrology, Hebei General Hospital, Shijiazhuang, China.
Hu Z; Department of Nephrology, Hebei General Hospital, Shijiazhuang, China.
Liu Y; Department of Nephrology, Hebei General Hospital, Shijiazhuang, China.; Graduate School, Hebei Medical University, Shijiazhuang, China.
Qin C; Department of Nephrology, Hebei General Hospital, Shijiazhuang, China.; Graduate School, Hebei North University, Zhangjiakou, China.
Chen X; Department of Nephrology, Hebei General Hospital, Shijiazhuang, China.
Shi Y; Department of Nephrology, Hebei General Hospital, Shijiazhuang, China.
Wang L; Department of Nephrology, Hebei General Hospital, Shijiazhuang, China.; Pokaż więcej
Źródło:: Renal failure [Ren Fail] 2023 Dec; Vol. 45 (1), pp. 2220412.
Typ publikacji:: Journal Article
MeSH Terms:: Vascular Calcification*/diagnostic imaging
Vascular Calcification*/etiology
Renal Insufficiency, Chronic*
Coronary Artery Disease*/diagnostic imaging
Coronary Artery Disease*/etiology
Humans ; Fibroblast Growth Factor-23 ; Calcifediol ; Complement C1q ; Risk Factors ; Tumor Necrosis Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Rhein attenuates angiotensin II-induced cardiac remodeling by modulating AMPK-FGF23 signaling.
Autorzy:: Lu W; Department of Cardiovascular Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, 324000, China. .
Zhu H; Department of Vascular Surgery, Changhai Hospital, Navy Medical University, Shanghai, 200433, China.
Wu J; Department of Cardiovascular Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, 324000, China.
Liao S; Department of Cardiovascular Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, 324000, China.
Cheng G; Department of Cardiovascular Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, 324000, China.
Li X; Department of Cardiovascular Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, 324000, China.; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2022 Jul 06; Vol. 20 (1), pp. 305. Date of Electronic Publication: 2022 Jul 06.
Typ publikacji:: Journal Article
MeSH Terms:: AMP-Activated Protein Kinases*/metabolism
Angiotensin II*/metabolism
Anthraquinones*/pharmacology
Fibroblast Growth Factor-23*/metabolism
Heart Failure*/drug therapy
Heart Failure*/metabolism
Ventricular Remodeling*/drug effects
Animals ; Fibrosis ; Hypertrophy ; Male ; Mice ; Mice, Inbred C57BL ; Myocytes, Cardiac/drug effects ; Myocytes, Cardiac/metabolism ; Rats

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Associations between endogenous sex hormones and FGF-23 among women and men in the Multi-Ethnic Study of Atherosclerosis.
Autorzy:: Ogunmoroti O; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.; Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Osibogun O; Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, Florida, United States of America.
Zhao D; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Mehta RC; Division of Nephrology and Hypertension, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.; The Jesse Brown Veterans Administration Medical Center, Chicago, Illinois, United States of America.
Ouyang P; Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Lutsey PL; Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, Minnesota, United States of America.
Robinson-Cohen C; Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Michos ED; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.; Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 May 25; Vol. 17 (5), pp. e0268759. Date of Electronic Publication: 2022 May 25 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:: Atherosclerosis*/blood
Cardiovascular Diseases*/blood
Fibroblast Growth Factor-23*/blood
Gonadal Steroid Hormones*/blood
Adult ; Aged ; Cross-Sectional Studies ; Estradiol/blood ; Female ; Humans ; Male ; Middle Aged ; Sex Hormone-Binding Globulin/metabolism ; Testosterone/blood

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: A New Approach to the Quantification of Fibroblast Growth Factor 23-An Array Surface Plasmon Resonance Imaging Biosensor.
Autorzy:: Tokarzewicz A; Department of Medical Biochemistry, Medical University of Bialystok, A. Mickiewicza 2C St., 15-089 Bialystok, Poland.
Ołdak Ł; Bioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K St., 15-245 Bialystok, Poland.
Młynarczyk G; Department of Urology, Medical University of Bialystok, M. Sklodowskiej-Curie 24A St., 15-276 Bialystok, Poland.
Klekotka U; Department of Physical Chemistry, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K St., 15-245 Bialystok, Poland.
Gorodkiewicz E; Bioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K St., 15-245 Bialystok, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Oct 18; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:: Journal Article
MeSH Terms:: Surface Plasmon Resonance*
Biosensing Techniques*/methods
Humans ; Fibroblast Growth Factor-23 ; Phosphates/metabolism ; Enzyme-Linked Immunosorbent Assay ; Fibroblast Growth Factors/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: A Combined Biomarker That Includes Plasma Fibroblast Growth Factor 23, Erythropoietin, and Klotho Predicts Short- and Long-Term Morbimortality and Development of Chronic Kidney Disease in Critical Care Patients with Sepsis: A Prospective Cohort.
Autorzy:: Toro L; Division of Nephrology, Department of Medicine, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.; Centro de Investigación Clínica Avanzada, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.; Centro de Pacientes Críticos, Clinica Las Condes, Santiago 7591047, Chile.
Rojas V; Centro de Investigación Clínica Avanzada, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.; Unidad de Pacientes Críticos, Departamento de Medicina, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Conejeros C; Division of Nephrology, Department of Medicine, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Ayala P; Centro de Investigación Clínica Avanzada, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Parra-Lucares A; Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8380456, Chile.
Ahumada F; Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8380456, Chile.
Almeida P; Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8380456, Chile.
Silva MF; Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8380456, Chile.
Bravo K; Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8380456, Chile.
Pumarino C; Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8380456, Chile.
Tong AM; Clinical Laboratory, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Pinto ME; Clinical Laboratory, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Romero C; Unidad de Pacientes Críticos, Departamento de Medicina, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Michea L; Division of Nephrology, Department of Medicine, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.; Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8380456, Chile.; Laboratorio de Fisiologia Integrativa, Facultad de Medicina Universidad de Chile, Santiago 8380456, Chile.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2023 Oct 03; Vol. 13 (10). Date of Electronic Publication: 2023 Oct 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Renal Insufficiency, Chronic*
Erythropoietin*
Acute Kidney Injury*
Sepsis*/complications
Humans ; Prospective Studies ; Fibroblast Growth Factor-23 ; Critical Care ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients.
Autorzy:: Fernández-Cladera Y; Division of Central Laboratory, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
Gómez-Bernal F; Division of Central Laboratory, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
García-González M; Division of Rheumatology, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
Quevedo-Abeledo JC; Division of Rheumatology, Hospital Doctor Negrín, 35010 Las Palmas de Gran Canaria, Spain.
González-Rivero AF; Division of Central Laboratory, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
de Vera-González A; Division of Central Laboratory, Hospital Universitario de Canarias, 38320 Tenerife, Spain.
Martín-González C; Division of Internal Medicine, Hospital Universitario de Canarias, 38320 Tenerife, Spain.; Department of Internal Medicine, University of La Laguna (ULL), 38200 Tenerife, Spain.
Nunes-Andrade AL; Department of Internal Medicine, University of La Laguna (ULL), 38200 Tenerife, Spain.
López-Mejías R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Instituto de Investigación Sanitaria Marqués de Valdecilla (IDIVAL), 39011 Santander, Spain.
González-Gay MÁ; Division of Rheumatology, IIS-Fundación Jiménez Díaz, 28015 Madrid, Spain.; Department of Medicine, University of Cantabria, 39011 Santander, Spain.; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.
Ferraz-Amaro I; Division of Rheumatology, Hospital Universitario de Canarias, 38320 Tenerife, Spain.; Department of Internal Medicine, University of La Laguna (ULL), 38200 Tenerife, Spain.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2023 Aug 05; Vol. 13 (8). Date of Electronic Publication: 2023 Aug 05.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Lupus Erythematosus, Systemic*
Autoimmune Diseases*
Arthritis*
Humans ; Fibroblast Growth Factor-23 ; Vitamin D

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Fibroblast Growth Factor 23 and Osteoporosis: Evidence from Bench to Bedside.
Autorzy:: Sirikul W; Department of Community Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
Siri-Angkul N; Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.; Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai 50200, Thailand.
Chattipakorn N; Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.; Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai 50200, Thailand.
Chattipakorn SC; Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai 50200, Thailand.; Department of Oral Biology and Diagnostic Sciences, Faculty of Dentistry, Chiang Mai University, Chiang Mai 50200, Thailand.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Feb 24; Vol. 23 (5). Date of Electronic Publication: 2022 Feb 24.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Fibroblast Growth Factor-23*
Osteoporosis*
Aged ; Bone and Bones/metabolism ; Fibroblast Growth Factors/metabolism ; Glucuronidase/genetics ; Humans ; Receptors, Fibroblast Growth Factor/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Cellular and Molecular Alterations Underlying Abnormal Bone Growth in X-Linked Hypophosphatemia.
Autorzy:: Fuente R; Division of Pediatrics, Department of Medicine, Faculty of Medicine, University of Oviedo, 33006 Oviedo, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.; Institute of Physiology, Center for Integrative Human Physiology (ZIHP), University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
García-Bengoa M; Division of Pediatrics, Department of Medicine, Faculty of Medicine, University of Oviedo, 33006 Oviedo, Spain.; Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, 30559 Hanover, Germany.
Fernández-Iglesias Á; Division of Pediatrics, Department of Medicine, Faculty of Medicine, University of Oviedo, 33006 Oviedo, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
Gil-Peña H; Division of Pediatrics, Department of Medicine, Faculty of Medicine, University of Oviedo, 33006 Oviedo, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.; Department of Pediatrics, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain.
Santos F; Division of Pediatrics, Department of Medicine, Faculty of Medicine, University of Oviedo, 33006 Oviedo, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.; Department of Pediatrics, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain.
López JM; Department of Morphology and Cellular Biology, Faculty of Medicine, University of Oviedo, 33006 Oviedo, Spain.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Jan 15; Vol. 23 (2). Date of Electronic Publication: 2022 Jan 15.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Familial Hypophosphatemic Rickets/*pathology
Fibroblast Growth Factor-23/*metabolism
Growth Plate/*pathology
PHEX Phosphate Regulating Neutral Endopeptidase/*genetics
Animals ; Antibodies, Neutralizing/pharmacology ; Antibodies, Neutralizing/therapeutic use ; Calcitriol/pharmacology ; Calcitriol/therapeutic use ; Familial Hypophosphatemic Rickets/drug therapy ; Familial Hypophosphatemic Rickets/genetics ; Fibroblast Growth Factor-23/drug effects ; Growth Hormone/pharmacology ; Growth Hormone/therapeutic use ; Growth Plate/drug effects ; Growth Plate/growth & development ; Humans ; Up-Regulation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Up-Regulation of Fibroblast Growth Factor 23 Gene Expression in UMR106 Osteoblast-like Cells with Reduced Viability.
Autorzy:: Münz S; Department of Physiology, University of Hohenheim, 70599 Stuttgart, Germany.
Feger M; Department of Physiology, University of Hohenheim, 70599 Stuttgart, Germany.
Edemir B; Department of Hematology and Oncology, Martin Luther University Halle-Wittenberg, 06120 Halle, Germany.
Föller M; Department of Physiology, University of Hohenheim, 70599 Stuttgart, Germany.; Pokaż więcej
Źródło:: Cells [Cells] 2021 Dec 23; Vol. 11 (1). Date of Electronic Publication: 2021 Dec 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Fibroblast Growth Factor-23/*genetics
Osteoblasts/*metabolism
Up-Regulation/*genetics
Animals ; Cell Line ; Cell Survival/drug effects ; Cell Survival/genetics ; Cisplatin/pharmacology ; Doxorubicin/pharmacology ; Fibroblast Growth Factor-23/metabolism ; Hydrazones/pharmacology ; Interleukin-6/metabolism ; NF-kappa B/metabolism ; Osteoblasts/drug effects ; Piperazines/pharmacology ; Rats ; Signal Transduction ; Up-Regulation/drug effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Relation Between Fibroblast Growth Factor-23 and Red Cell Distribution Width in Patients with End-Stage Renal Disease Undergoing Hemodialysis.
Autorzy:: Ramezanzade E
Khosravi M; Urology Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. .
Monfared A
Mirpour Hassankiadeh SH
Namdar M; Pokaż więcej
Źródło:: Iranian journal of kidney diseases [Iran J Kidney Dis] 2021 Dec; Vol. 15 (6), pp. 426-432.
Typ publikacji:: Journal Article
MeSH Terms:: Fibroblast Growth Factor-23*
Kidney Failure, Chronic*/diagnosis
Kidney Failure, Chronic*/therapy
Aged ; Cross-Sectional Studies ; Erythrocyte Indices ; Fibroblast Growth Factors ; Humans ; Middle Aged ; Renal Dialysis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Fibroblast growth factor 23-Klotho and mineral metabolism in the first year after pediatric kidney transplantation: A single-center prospective study.
Autorzy:: Kubota M; Department of Nephrology, Toho University, Faculty of Medicine, Tokyo, Japan.
Hamasaki Y; Department of Nephrology, Toho University, Faculty of Medicine, Tokyo, Japan.
Hashimoto J; Department of Nephrology, Toho University, Faculty of Medicine, Tokyo, Japan.
Aoki Y; Department of Nephrology, Toho University, Faculty of Medicine, Tokyo, Japan.
Kawamura T; Department of Nephrology, Toho University, Faculty of Medicine, Tokyo, Japan.
Saito A; Department of Nephrology, Toho University, Faculty of Medicine, Tokyo, Japan.
Yuasa R; Department of Nephrology, Toho University, Faculty of Medicine, Tokyo, Japan.
Muramatsu M; Department of Nephrology, Toho University, Faculty of Medicine, Tokyo, Japan.
Komaba H; Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan.
Toyoda M; Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan.
Fukagawa M; Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan.
Shishido S; Department of Pediatric Nephrology, Toho University, Faculty of Medicine, Tokyo, Japan.
Sakai K; Department of Nephrology, Toho University, Faculty of Medicine, Tokyo, Japan.; Pokaż więcej
Źródło:: Pediatric transplantation [Pediatr Transplant] 2023 Mar; Vol. 27 (2), pp. e14440. Date of Electronic Publication: 2022 Dec 05.
Typ publikacji:: Journal Article
MeSH Terms:: Kidney Transplantation*
Adolescent ; Child ; Humans ; Infant, Newborn ; Fibroblast Growth Factor-23 ; Fibroblast Growth Factors/metabolism ; Glucuronidase/metabolism ; Minerals/metabolism ; Phosphorus ; Prospective Studies ; Klotho Proteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Fibroblast Growth Factor-23"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język